Ignite Creation Date:
2024-05-05 @ 11:57 PM
Last Modification Date:
2024-10-26 @ 10:42 AM
Study NCT ID:
NCT01456351
Status:
COMPLETED
Last Update Posted:
2013-02-12
First Post:
2011-10-11
Brief Title:
Bendamustine Plus Rituximab Versus Fludarabine Plus Rituximab
Sponsor:
University of Giessen
Organization:
University of Giessen
Organization Data
Organization:
University of Giessen
Class:
OTHER
Study ID:
NHL 2-2003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Giessen
Lead Sponsor Class:
OTHER
Responsible Party:
Jurgen Barth
Responsible Party Title:
Professor Mathias Rummel
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Giessen
Old Name:
None
Old Organization:
None